BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37684055)

  • 1. Bempedoic Acid Unveils Therapeutic Potential in Non-Alcoholic Fatty Liver Disease: Suppression of the Hepatic PXR-SLC13A5/ACLY Signaling Axis.
    Sun Q; Guo Y; Hu W; Zhang M; Wang S; Lei Y; Meng H; Li N; Xu P; Li Z; Lin H; Huang F; Qiu Z
    Drug Metab Dispos; 2023 Dec; 51(12):1628-1641. PubMed ID: 37684055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation on Citrate Influx and Metabolism through Inhibiting SLC13A5 and ACLY: A Novel Mechanism Mediating the Therapeutic Effects of Curcumin on NAFLD.
    Sun Q; Niu Q; Guo Y; Zhuang Y; Li X; Liu J; Li N; Li Z; Huang F; Qiu Z
    J Agric Food Chem; 2021 Aug; 69(31):8714-8725. PubMed ID: 34323067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced acetylation of ATP-citrate lyase promotes the progression of nonalcoholic fatty liver disease.
    Guo L; Guo YY; Li BY; Peng WQ; Chang XX; Gao X; Tang QQ
    J Biol Chem; 2019 Aug; 294(31):11805-11816. PubMed ID: 31197036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hrd1-mediated ACLY ubiquitination alleviate NAFLD in db/db mice.
    Li K; Zhang K; Wang H; Wu Y; Chen N; Chen J; Qiu C; Cai P; Li M; Liang X; Su D
    Metabolism; 2021 Jan; 114():154349. PubMed ID: 32888949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Steatotic Cells, ATP-Citrate Lyase mRNA Is Efficiently Translated through a Cap-Independent Mechanism, Contributing to the Stimulation of De Novo Lipogenesis.
    Siculella L; Giannotti L; Testini M; Gnoni GV; Damiano F
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32054087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bempedoic acid for nonalcoholic fatty liver disease: evidence and mechanisms of action.
    Roglans N; Laguna JC; Alegret M
    Curr Opin Lipidol; 2023 Aug; 34(4):141-146. PubMed ID: 36942869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine Triphosphate Citrate Lyase and Fatty Acid Synthesis Inhibition: A Narrative Review.
    Duarte Lau F; Giugliano RP
    JAMA Cardiol; 2023 Sep; 8(9):879-887. PubMed ID: 37585218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of citrate cotransporter Slc13a5/mINDY by RNAi improves hepatic insulin sensitivity and prevents diet-induced non-alcoholic fatty liver disease in mice.
    Brachs S; Winkel AF; Tang H; Birkenfeld AL; Brunner B; Jahn-Hofmann K; Margerie D; Ruetten H; Schmoll D; Spranger J
    Mol Metab; 2016 Nov; 5(11):1072-1082. PubMed ID: 27818933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate.
    Zhao S; Jang C; Liu J; Uehara K; Gilbert M; Izzo L; Zeng X; Trefely S; Fernandez S; Carrer A; Miller KD; Schug ZT; Snyder NW; Gade TP; Titchenell PM; Rabinowitz JD; Wellen KE
    Nature; 2020 Mar; 579(7800):586-591. PubMed ID: 32214246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The citrate transporters SLC13A5 and SLC25A1 elicit different metabolic responses and phenotypes in the mouse.
    Fernandez-Fuente G; Overmyer KA; Lawton AJ; Kasza I; Shapiro SL; Gallego-Muñoz P; Coon JJ; Denu JM; Alexander CM; Puglielli L
    Commun Biol; 2023 Sep; 6(1):926. PubMed ID: 37689798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paradoxical activation of transcription factor SREBP1c and de novo lipogenesis by hepatocyte-selective ATP-citrate lyase depletion in obese mice.
    Yenilmez B; Kelly M; Zhang GF; Wetoska N; Ilkayeva OR; Min K; Rowland L; DiMarzio C; He W; Raymond N; Lifshitz L; Pan M; Han X; Xie J; Friedline RH; Kim JK; Gao G; Herman MA; Newgard CB; Czech MP
    J Biol Chem; 2022 Oct; 298(10):102401. PubMed ID: 35988648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATP-citrate lyase: genetics, molecular biology and therapeutic target for dyslipidemia.
    Burke AC; Huff MW
    Curr Opin Lipidol; 2017 Apr; 28(2):193-200. PubMed ID: 28059952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetrahydropalmatine ameliorates hepatic steatosis in nonalcoholic fatty liver disease by switching lipid metabolism via AMPK-SREBP-1c-Sirt1 signaling axis.
    Yin X; Liu Z; Wang J
    Phytomedicine; 2023 Oct; 119():155005. PubMed ID: 37562090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATP-citrate lyase (ACLY) in lipid metabolism and atherosclerosis: An updated review.
    Feng X; Zhang L; Xu S; Shen AZ
    Prog Lipid Res; 2020 Jan; 77():101006. PubMed ID: 31499095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bempedoic acid: effects on lipoprotein metabolism and atherosclerosis.
    Burke AC; Telford DE; Huff MW
    Curr Opin Lipidol; 2019 Feb; 30(1):1-9. PubMed ID: 30586346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATP Citrate Lyase and LncRNA NONMMUT010685 Play Crucial Role in Nonalcoholic Fatty Liver Disease Based on Analysis of Microarray Data.
    Ma TT; Huang C; Ni Y; Yang Y; Li J
    Cell Physiol Biochem; 2018; 51(2):871-885. PubMed ID: 30466110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATP citrate lyase inhibitor Bempedoic Acid alleviate long term HFD induced NASH through improvement in glycemic control, reduction of hepatic triglycerides & total cholesterol, modulation of inflammatory & fibrotic genes and improvement in NAS score.
    Sanjay KV; Vishwakarma S; Zope BR; Mane VS; Mohire S; Dhakshinamoorthy S
    Curr Res Pharmacol Drug Discov; 2021; 2():100051. PubMed ID: 34909677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the mitochondrial citrate carrier, Slc25a1, reverts steatosis, glucose intolerance, and inflammation in preclinical models of NAFLD/NASH.
    Tan M; Mosaoa R; Graham GT; Kasprzyk-Pawelec A; Gadre S; Parasido E; Catalina-Rodriguez O; Foley P; Giaccone G; Cheema A; Kallakury B; Albanese C; Yi C; Avantaggiati ML
    Cell Death Differ; 2020 Jul; 27(7):2143-2157. PubMed ID: 31959914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of ATP citrate lyase induces triglyceride accumulation with altered fatty acid composition in cancer cells.
    Migita T; Okabe S; Ikeda K; Igarashi S; Sugawara S; Tomida A; Soga T; Taguchi R; Seimiya H
    Int J Cancer; 2014 Jul; 135(1):37-47. PubMed ID: 24310723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corydalis saxicola Bunting total alkaloids improve NAFLD by suppressing de novo lipogenesis through the AMPK-SREBP1 axis.
    Guo Y; Sun Q; Wang S; Zhang M; Lei Y; Wu J; Wang X; Hu W; Meng H; Li Z; Xu L; Huang F; Qiu Z
    J Ethnopharmacol; 2024 Jan; 319(Pt 1):117162. PubMed ID: 37690477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.